Skip to main content

Incontinence, Urinary

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Coloplast
ColoplastAustralia - Mulgrave
3 programs
Coloplast Test CatheterN/A1 trial
Coloplast Test CatheterN/A1 trial
Coloplast test catheterN/A1 trial
Active Trials
NCT02965066Completed28Est. Nov 2016
NCT02965105Completed28Est. Dec 2016
NCT02966015Completed153Est. Jun 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ColoplastColoplast Test Catheter
ColoplastColoplast Test Catheter
ColoplastColoplast test catheter

Clinical Trials (3)

Total enrollment: 209 patients across 3 trials

NCT02965105ColoplastColoplast Test Catheter

Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers

Start: Nov 2016Est. completion: Dec 201628 patients
N/ACompleted
NCT02965066ColoplastColoplast Test Catheter

Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers

Start: Sep 2016Est. completion: Nov 201628 patients
N/ACompleted
NCT02966015ColoplastColoplast test catheter

Product Evaluation of a Newly Developed Intermittent Catheter.

Start: May 2016Est. completion: Jun 2016153 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.